IL6 and Alzheimer disease: For example, microglial activation, accompanied by increased levels of pro-inflammatory mediators, such as Tumor necrosis factor-α (TNF-α), Interleukin-1β (IL-1β), and IL-6, prostaglandins, and reactive oxygen and nitrogen species, is observed in the AD brain at all stages of the disease [23].